Abstract
In this essay, I will talk about two papers that were published. In order to demonstrate the activities of inactive ingredients, these two papers reported the impact of inactive ingredients on biological targets through some experiments. Because as the development of pharmaceutical chemistry, more and more people pay more attention on medication safety. As a result, in this paper, I will use the Thimerosal, Glycyrrhizin and Butylparaben as the main experiment examples to help explain the discovery of the effect of inactive ingredients on biological targets. Because there was not systematic research, this article will discuss this topic about materials and methods in order to have a better understanding.
Publisher
Darcy & Roy Press Co. Ltd.
Reference10 articles.
1. What Is an Inhibitory Constant (Ki) and How Does It Relate to Understanding Drug Interactions?” Ebmconsult.com, 2015, www.ebmconsult.com/articles/inhibitory-constant-ki-drug-interactions.
2. R. R. Neubig et al. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev (2003) vol. 55 (4) pp. 597-606.
3. “50% of What? How Exactly Are IC50 and EC50 Defined? - FAQ 1356 - GraphPad.” Graphpad.com, 2010, www.graphpad.com/support/faq/50-of-what-how-exactly-are-ic50-and-ec50-defined/.
4. Ruth Williams. “What does the inert component of the drug do?.” Www.bilibili.com, edited by Jin A, 5 Mar. 2022, www.bilibili.com/read/cv15529700/.
5. Pottel, Joshua, et al. “The Activities of Drug Inactive Ingredients on Biological Targets.” Science, vol. 369, no. 6502, July 2020, pp. 403–13, https://doi.org/10.1126/science.aaz9906.